Industry News
New Microfluidic Device Could Be Used To Diagnose And Monitor Cancer And Other Diseases.
Feb 24, 2012
Separating complex mixtures of cells, such as those found in a blood sample, can offer valuable information for diagnosing and treating disease. However, it may be necessary to search through billions of other cells to collect rare cells such as tumor cells, stem cells or fetal cells... Read More
Teaching Program Evaluated For Breaking Bad News To Patients
Feb 24, 2012
Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news... Read More
Promise Of New Drugs Following Cancer Discovery
Feb 24, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered how a protein "master regulator" goes awry, leading to metastasis, the fatal step of cancer... Read More
Promise Of New Drugs Following Cancer Discovery
Feb 24, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered how a protein "master regulator" goes awry, leading to metastasis, the fatal step of cancer... Read More
Insight Into Cancer Progression
Feb 24, 2012
The University of Kentucky has announced that Dr. Daret St. Clair, the James Graham Brown Endowed Chair and professor of toxicology, has published the first comprehensive study that provides insight into the relationship between two types of suppressors in cancerous tumors. The results will enhance the understanding of transcriptional mechanisms in carcinogenesis... Read More
Zelboraf (Vemurafenib) Doubles Survival Times For Metastatic Melanoma Patients
Feb 23, 2012
Zelboraf (vemurafenib) was found to double the survival times of patients with BRAF V600-Mutant Advanced Melanoma, researchers from UCLA's Jonsson Comprehensive Cancer Center, and 12 other sites reported in NEJM (New England Journal of Medicine. The authors added that the findings of their study will alter how this deadly skin cancer is treated... Read More
Zelboraf (Vemurafenib) Doubles Survival Times For Metastatic Melanoma Patients
Feb 23, 2012
Zelboraf (vemurafenib) was found to double the survival times of patients with BRAF V600-Mutant Advanced Melanoma, researchers from UCLA's Jonsson Comprehensive Cancer Center, and 12 other sites reported in NEJM (New England Journal of Medicine. The authors added that the findings of their study will alter how this deadly skin cancer is treated... Read More
Colonoscopy May Halve Colon Cancer Deaths, Long Term Study
Feb 23, 2012
New research led by the Memorial Sloan-Kettering Cancer Center in the US has for the first time found that removing precancerous polyps during colonoscopy may halve the risk of dying from the disease... Read More
Colonoscopy May Halve Colon Cancer Deaths, Long Term Study
Feb 23, 2012
New research led by the Memorial Sloan-Kettering Cancer Center in the US has for the first time found that removing precancerous polyps during colonoscopy may halve the risk of dying from the disease... Read More
Researchers Discover New Member Of The Breast-Cancer Gene Network
Feb 23, 2012
The infamous BRCA genes do not act alone in causing cancer; there is a molecular syndicate at work preventing the way cells normally repair breaks in DNA that is at the root of breast cancer. But finding all of the BRCA molecular collaborators has been elusive... Read More
Previous Page Next Page